Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
200 participants
OBSERVATIONAL
2018-03-28
2021-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Developing Biomarkers for Fibromyalgia
NCT00932061
Breathing and Chest Wall Mobility in People With Fibromyalgia.
NCT03495687
Prognostic Factors for Work Disability in Patients With Chronic Widespread Pain and Fibromyalgia.
NCT04862520
Effectiveness of the Sana Device on Fibromyalgia Symptoms
NCT05394610
Effect of Temperature on Pain and Brown Adipose Activity in Fibromyalgia
NCT01322425
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Fibromyalgia patients will be recruited into two groups-- one that uses opioids and the other that does not. Blood will be collected every 6 months for two years. The serum will be used to assay for levels of S100B and BDNF, The pressure-pain threshold (PPT) data, as part of standard of care, will also be collected. Correlation will the be assessed.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Opioid Usage
Patients that are currently diagnosed with fibromyalgia and taking opioids.
No interventions assigned to this group
No Opioid Usage
Patients that are currently diagnosed with fibromyalgia and are not taking opioids.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
American Osteopathic Association
OTHER
Rowan University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Venkat Venkataraman, PhD
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Venkateswar Venkataraman, PhD
Role: PRINCIPAL_INVESTIGATOR
Rowan University School of Osteopathic Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rowan University School of Osteopathic Medicine
Stratford, New Jersey, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pro2017001740
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.